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Abstract: A male mixed breed street dog (age unknown) presented with an ocular mass and multiple ulcerated subcutaneous nodules
on both hind limbs which bled easily when touched. Inspection of the genital organs revealed that no masses were present. The ocular
mass and nodules were diagnosed as a transmissible venereal tumor (TVT) by fine-needle aspiration cytology. The total remission
of the tumor was achieved after 5 applications of vincristine sulfate. The dog was adopted during the remission period, but 5 months
after adoption he developed neurological signs and died. The necropsy revealed a mass located in the trunk of the corpus callosum of
the right hemisphere of the brain. The cytological, histological, and PCR findings of the brain mass were consistent with a TVT. These
findings highlight the need to consider the aggressive metastatic potential of canine TVT, even after apparently effective chemotherapy.
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1. Introduction
Transmissible venereal tumor (TVT) is a neoplasm of round
cells that occurs in dogs. A recent study of the University
of Cambridge found that the distribution is correlated
mostly with the presence of street dogs that mate freely
[1]. The tumor is transmitted via direct transplantation of
viable cells during sexual intercourse. TVT prevalence is
greater in populations of young, sexually active dogs [2,3].
A study of TVT prevalence in dogs in Mexico City found
that the age at presentation was typically 3–4 years old [4].
Dogs with a suppressed immune system are more likely
to have a more severe disease [2,5,6]. Due to the mode of
transmission, this neoplasm mainly affects the genitals [5–
7], although parenchymal organs and even the brain can
be affected [8,9]. There are few reports of this neoplasm
affecting extragenital locations. Most reports describe
tumors in anatomical locations that can be associated with
social behaviors, including sniffing, scratching, and biting
[6,7,10]. Among the few rare reported cases of extragenital
primary TVT [6,10,11], nasal, oral, and subcutaneous
TVTs without evidence of genital tumors have been found
[3,6,7,11]. The values for incidence of metastasis are
between 1% and 5%. Metastatic TVTs have been found in
peritoneal fat, tonsils, eyes, liver, spleen, lungs, kidneys,
regional lymph nodes, skin, muscle, and brain tissues
[1,2,5,7]. When present in brain tissues, ataxia and other

neurological signs (e.g., loss of vision, smell, and hearing)
occur, even after an effective treatment. TVT is typically
diagnosed using histological or cytological studies, or
both. The treatment for this neoplasm is based on the
application of vincristine sulfate at weekly intervals for a
total of 4–8 applications; this protocol generally results in
tumor remission [1,3,6,7,11].
2. Case history
A mixed breed, young male street dog of unknown age
was brought to the Veterinary Pathology Laboratory at the
Autonomous University of Sinaloa. He was undernourished
and had severe purulent conjunctivitis and an ocular mass
in the right eye (Figure 1A). Abundant subcutaneous
ulcerated nodules of 1–2 cm in diameter that bled easily
when touched were found on both hind limbs (Figure
1B). Due to the presence of the ocular mass, the nodule’s
characteristics, and the dog’s history, a TVT was suspected.
However, an inspection of the genital area revealed no
masses. Fine-needle aspiration cytology was performed.
A microscopic examination revealed abundant round cells
showing a moderated cytoplasmic-nucleus relationship,
prominent nucleoli, and, in some cells, cytoplasmic
vacuolization. Cells with atypical mitosis were abundant.
These findings were consistent with TVT. A chemotherapy
protocol with vincristine sulfate at a dose of 0.7 mg/m2
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was initiated. The drug was given intravenously at weekly
intervals. There was a noticeable improvement by the third
application, including a significant decrease in the size of
the ocular mass. Five applications were necessary for total
remission of the tumors (Figure 1C). Once recovered,
the dog was adopted. Five months after adoption, the
dog was observed walking in circles. He was hospitalized
with ataxia and anorexia, where progressive loss of sight,
hearing, and smell was also observed, and he died 15 days
later. A necropsy revealed a 2.5 cm diameter nodular lesion
in the trunk of the corpus callosum of the right hemisphere

of the brain (Figure 2A). The cytological findings were
compatible with TVT (Figure 2B). Histologically, solid
tissue was found that had rich conjunctival stroma in some
areas. The round cells were abundant in cytoplasm and
were vacuolated with prominent nucleoli and perinuclear
chromatin. The cells were arranged in solid groups and
in some areas they formed beads. In addition to discrete
pockets of lymphoid cells, abundant mitoses and some
apoptotic cells were present (Figure 2C). The histological
diagnosis was TVT. Polymerase chain reaction (PCR)
was used to confirm the presence of TVT. A commercial

Figure 1. A) Cauliflower-like mass in the right eye. B) Multiple subcutaneous nodules in hind limbs with characteristics that are
consistent with a transmissible venereal tumor. An overall poor condition of health was apparent. C) Total remission of the ocular mass
and of the nodules on the hind limbs occurred after vincristine sulfate chemotherapy. There was also a clear improvement in the overall
condition of the patient, including body weight, skin, and coat.
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extraction matrix (QIAamp) was used to extract DNA from
the tissue found in the brain. Primer sequences specific to
the regions of the LINE-c-myc gene rearrangement MycS2
(5′-ATTCCTACGAATGAATGATTGGCCAGA-3′)
and
LINE
AS-1
(5′-CAGACACATAGATCAGTGGAACAGAAT-3′)
were used [12]. Amplification was performed using a
thermocycler (Bio-Rad, MJ Mini Personal Thermal Cycler).
The mixture for amplification contained 5 µL of DNA
mold, 1 µL (10 pmol L–1) of each of the oligonucleotides
(forward and reverse), 12.5 µL of PCR SuperMix (22 mM
Tris-HCl, 55 mM KCl, 1.64 mM MgCl2, 220 M dGTP, 220
M dATP, 220 M dTTP, 220 M dCTP, 22 U/mL Taq DNA
recombinant polymerase), and 1.5 µL of MgCl2 (50 mM).
Nuclease-free water was added to obtain the final volume

of 25 µL. The PCR thermal cycling consisted of 35 cycles of
94 °C for 1 min (denaturation), 64 °C for 50 s (annealing),
and 72 °C for 1 min (extension). The PCR products (desired
amplicon was 550 bp) were then resolved using 1.5% (w/v)
agarose gel electrophoresis in 1.5% agarose gels predyed
with GelRed (solution 1:10,000) and in electrophoresis
buffer of 0.5X Tris-EDTA. A molecular weight marker of
100 bp (Bio-Rad) was used, and the gels were examined
in an imaging system (Gel Documentation System EZ
GelDoc) and photographed for analysis (Figure 2D).
3. Results and discussion
The cytological, histological, and PCR findings of the brain
mass were consistent with a TVT. Dogs with suppressed
immune systems have increased severity of disease

Figure 2. A) A brain mass of 2.5 cm diameter in the right hemisphere, which was sampled using fine-needle aspiration (black
arrow). Histopathology and cytology were used to determine the characteristics of the mass. B) On cytology, the TVT cells showed
a predominance of round cells with abundant pale cytoplasm and distinct, punctate cytoplasmic vacuoles. Large neuron cell body
(thin arrow). Papanicolaou stain. Bar: 20 µm. C) Histopathology image with round cells with abundant cytoplasm, vacuolated, with
prominent nucleoli and perinuclear chromatin, divided into packets by fine fibrous stroma. H&E. Bar: 50 µm. D) The PCR results for
detection of the region associated with the LINE-c-myc gene rearrangement MycS-2 and LINE AS-1. Lane 1, MPM, 100 bp; lane 2,
positive control; lane 3, DNA from nodular lesion found in the trunk of the corpus callosum; lane 4, negative control.
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[2,5,6,13], which is compatible with the characteristics
of this dog exposed to severe malnutrition that likely
caused immunosuppression. In some cases, spontaneous
regression of the tumor has been observed in healthy
animals with vigorous immune systems [14]. The genitals
of this dog were without a neoplastic TVT lesion, which
suggests that the origin of the primary neoplasm was
the skin. The presence of the eye mass and the nodules
on the hind legs may be associated with social behavior
during mating [6,7,10]. Before being adopted the dog
was living on the streets and would have been exposed
to a high risk of TVT transmission. With respect to the
cellular spread of the tumor, there are other reports of
TVT cerebral metastasis, but in all of them, the primary
neoplasm was located in the genitals [8,9]. Reports of
extragenital primary TVT, however, are rare [6,10,11].
Among the few cases of this type, nasal, oral, and
subcutaneous TVTs without evidence of genital tumors
have been observed [3,6,7,11]. Reports of metastasis are
less than 1%–5%. When metastasis does occur, it has
been found in peritoneal fat, tonsils, eyes, liver, spleen,
lungs, kidneys, regional lymph nodes, skin, muscle, and
brain tissues [1,2,5,13]. In the present case, ataxia and
other neurological signs such as loss of vision, smell, and
hearing were likely associated with the neoplastic lesion in
the trunk of the corpus callosum of the right hemisphere
of the brain. The neurological signs continued even after
successful treatment with vincristine sulfate. Pinczowski
et al. reported similar results after vincristine sulfate
treatment of a dog that also presented with neurological
disturbances [8]. The location of the tumor that affected

this dog, however, corresponded to what has been found
in other cases; exposure of the area with tumor cells can
occur because large numbers of blood vessels are present
in this area of the brain [8]. Treatment is based on the
application of vincristine sulfate to doses of 0.025 mg/kg IV
or 0.5–0.7 mg/m2 at weekly intervals for 4 to 8 applications;
use of this protocol generally results in tumor remission
[1,3,6,7,13]. In this case, total remission was achieved after
5 doses, without the need for complementary treatments.
There was no resistance associated with the treatment.
Despite the successful result of the initial therapy using
vincristine, viable tumor cells likely spread from the eye
to the brain tissues due to the close anatomical proximity
and then caused the nervous system alterations and the
subsequent death of the patient. This report presents a
case of canine TVT with metastasis to brain, even after
effective chemotherapy and without having any genital
tumor. In cases of this type of presentation, clinicians
should consider the other round cell tumors as differential
diagnoses (histiocytoma, histiocytic sarcoma, mast cell
tumor, plasma cell tumor, and cutaneous lymphoma),
even when there is no macroscopic involvement of the
genital organs. Because TVT neoplastic cells can spread
to the central nervous system, in patients with neoplastic
lesions in the conjunctival mucosa, periodic follow-ups
and clinical reviews should be performed after apparent
complete remission of neoplasia with chemotherapy.
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